Notably, previous studies reported RACK1 to be closely associated with the prognosis of patients with cancer because of its involvement in several tumor-related signaling pathways, such as the Src/FAK (Ou et al., 2022), AKT/mTOR (Zhang et al., 2016), IKK/NF-κB (Yao et al., 2014), and Wnt/ β-catenin pathways (Yu et al., 2021). This evidence concerns the gene RACK1 and cancer.